Kathryn Sarah Schwenzer
Hoffmann-La Roche
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kathryn Sarah Schwenzer.
Therapeutic Drug Monitoring | 1993
Joseph P. Laurino; John McKay; Ellyn Fischberg; Kathryn Sarah Schwenzer; Richard Allen Kaufman
The performance of the ROCHE FP NAPA reagent, a newly reformulated monoclonal antibody-based fluorescence polarization immunoassay (FPIA) for TV-acetylprocainamide, was compared with two commercially available polyclonal antibody-based immunoassays, the Abbott TDx and Syva EMIT. Although excellent correlation was observed between the ROCHE FP NAPA reagent and the Syva EMIT reagent, a positive bias was observed in the correlation between the ROCHE FP NAPA reagent and the Abbott TDx reagent. The bias in the TDx method was investigated further by the concurrent high-performance liquid chromatography (HPLC) analysis of patient samples. Insignificant differences (p > 0.05) were observed between the HPLC and ROCHE FP values. The TDx system, however, yielded significantly higher (p < 0.0005) results than did HPLC.
Archive | 1992
Raymond A. Hui; Kathryn Sarah Schwenzer
Archive | 1990
Richard Allen Kaufman; Kathryn Sarah Schwenzer; Lynne Ling-Tzyy Wu
Archive | 1995
Mitali Ghoshal; Kathryn Sarah Schwenzer; Robert Sundoro Wu
Archive | 1990
Richard Allen Kaufman; Kathryn Sarah Schwenzer; Lynne Ling-Tzyy Wu
Archive | 1993
Raymond A. Hui; Kathryn Sarah Schwenzer
Archive | 2001
Raymond A. Hui; Kathryn Sarah Schwenzer; サラ シュヴェンツァー キャスリン; アルバート フイ レイモンド
Archive | 1998
Charles Minnan Cheng; Kathryn Sarah Schwenzer; Raymond Thomas Wong
Archive | 1998
Charles Minnan Cheng; Kathryn Sarah Schwenzer; Raymond Thomas Wong
Therapeutic Drug Monitoring | 1997
Kathryn Sarah Schwenzer; R. Wong; C. Cheng; L. Vitone; S. Salamone